Displaying drugs 15401 - 15425 of 15745 in total
Domofenogene zalfaparvovec
Domofenogene zalfaparvovec, formerly known as BMN-307, is an investigational AAV5-phenylalanine hydroxylase (PAH) gene therapy developed by BioMarin Pharmaceutical.
Experimental
Ifezuntirgene inilparvovec
Experimental
Ixoberogene soroparvovec
Investigational
Zaftuclenegene piruparvovec
Experimental
Human Laminin-111
Investigational
Recombinant methionyl brain-derived neurotrophic factor
Investigational
BBP-812
Investigational
TSHA-120
Investigational
Vesleteplirsen
Investigational
AT-GTX-502
AT-GTX-502 is an experimental, one-time gene therapy that uses AAV9 to deliver a functional copy of CLN3.
Investigational
BMN-045
Experimental
Withdrawn
AMZ002
AMZ002 is a sterile injectable hormone developed as a purified synthetic polypeptide alternative to current FDA-approved epileptic seizure treatments.
Investigational
AVI-014
AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF).
Investigational
Autologous Human Peripheral Blood Lymphocytes
Investigational
ETBX-041
Investigational
P-2045 Re-188
Investigational
ALM201
ALM201 is an anti-angiogenic synthetic peptide identified from the endogenous human protein, FKBPL. It is being investigated in the treatment of various cancers.
Investigational
Pritumumab
Investigational
Tamrintamab pamozirine
Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.
Investigational
JCAR014
Investigational
M-032
Investigational
Galinpepimut-S
Investigational
Pelareorep
Investigational
G305
G305 is a recombinant NY-ESO-1 protein plus glucopyranosyl lipid A (GLA) in a stable emulsion (SE). G305 is an active component of CMB305 along with LV305.
Investigational
Hepcortespenlisimut-L
Investigational
Displaying drugs 15401 - 15425 of 15745 in total